JFGIW
NVO

Johnson Financial Group Inc (Wisconsin)’s Novo Nordisk NVO Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.2K Buy
525
+225
+75% +$9.67K ﹤0.01% 542
2026
Q1 		$11.4K Sell
300
-27
-8% -$1.28K ﹤0.01% 624
2025
Q4 		$16.6K Sell
327
-357
-52% -$18.3K ﹤0.01% 610
2025
Q3 		$38K Buy
684
+384
+128% +$22.5K ﹤0.01% 644
2025
Q2 		$20.7K Hold
300
– – ﹤0.01% 552
2025
Q1 		$21.2K Hold
300
– – ﹤0.01% 711
2024
Q4 		$25.3K Sell
300
-101
-25% -$10.9K ﹤0.01% 566
2024
Q3 		$47.7K Buy
401
+30
+8% +$4K ﹤0.01% 522
2024
Q2 		$53K Sell
371
-291
-44% -$38.6K ﹤0.01% 446
2024
Q1 		$85.5K Buy
662
+160
+32% +$19K ﹤0.01% 371
2023
Q4 		$51.9K Buy
502
+68
+16% +$6.72K ﹤0.01% 443
2023
Q3 		$39.5K Hold
434
– – ﹤0.01% 419
2023
Q2 		$35.1K Sell
434
-72
-14% -$5.88K ﹤0.01% 440
2023
Q1 		$40.6K Buy
+506
New +$35.9K ﹤0.01% 423
2020
Q1 		– Sell
-770
Closed -$22K – 503
2019
Q4 		$22K Sell
770
-44
-5% -$1.22K ﹤0.01% 362
2019
Q3 		$21K Buy
814
+286
+54% +$7.23K ﹤0.01% 405
2019
Q2 		$13K Hold
528
– – ﹤0.01% 444
2019
Q1 		$14K Sell
528
-330
-38% -$8.11K ﹤0.01% 416
2018
Q4 		$20K Sell
858
-148
-15% -$3.29K ﹤0.01% 385
2018
Q3 		$24K Buy
1,006
+148
+17% +$3.61K ﹤0.01% 384
2018
Q2 		$20K Hold
858
– – ﹤0.01% 404
2018
Q1 		$21K Hold
858
– – ﹤0.01% 408
2017
Q4 		$23K Hold
858
– – ﹤0.01% 416
2017
Q3 		$21K Buy
858
+330
+63% +$7.46K ﹤0.01% 416
2017
Q2 		$11K Sell
528
-382
-42% -$7.71K ﹤0.01% 468
2017
Q1 		$16K Buy
+910
New +$15.8K ﹤0.01% 541
2016
Q4 		– Sell
-324
Closed -$7K – 701
2016
Q3 		$7K Hold
324
– – ﹤0.01% 618
2016
Q2 		$9K Sell
324
-38
-10% -$1.04K ﹤0.01% 671
2016
Q1 		$10K Sell
362
-104
-22% -$2.79K ﹤0.01% 610
2015
Q4 		$14K Buy
466
+104
+29% +$2.88K ﹤0.01% 594
2015
Q3 		$10K Buy
362
+38
+12% +$1.08K ﹤0.01% 653
2015
Q2 		$9K Hold
324
– – ﹤0.01% 689
2015
Q1 		$9K Hold
324
– – ﹤0.01% 694
2014
Q4 		$7K Hold
324
– – ﹤0.01% 675
2014
Q3 		$8K Buy
+324
New +$7.46K ﹤0.01% 624
2014
Q2 		– Sell
-250
Closed -$6K – 711
2014
Q1 		$6K Sell
250
-150
-38% -$3.2K ﹤0.01% 623
2013
Q4 		$7K Hold
400
– – ﹤0.01% 604
2013
Q3 		$7K Sell
400
-150
-27% -$2.52K ﹤0.01% 586
2013
Q2 		$9K Buy
+550
New +$9.15K ﹤0.01% 575

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s NVO Position: Q2 2026 in Review

Johnson Financial Group Inc (Wisconsin) increased its Novo Nordisk (NVO) stake by 75% in Q2 2026, buying an estimated $9.67K and bringing the position to 525 shares worth $25.2K. The position accounts for ﹤0.01% of the portfolio, ranked #542.

Johnson Financial Group Inc (Wisconsin) first reported a position in NVO in Q2 2013 and has held it in 39 quarters since. The position peaked at $85.5K in Q1 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Johnson Financial Group Inc (Wisconsin) held 525 shares of Novo Nordisk worth $25.2K as of Q2 2026.
  • Johnson Financial Group Inc (Wisconsin) bought 225 Novo Nordisk shares in Q2 2026, an estimated $9.67K.
  • Novo Nordisk made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q2 2026, its #542 holding.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Novo Nordisk in Q2 2013 and has held it in 39 quarters since.
  • Johnson Financial Group Inc (Wisconsin)'s Novo Nordisk position peaked at $85.5K in Q1 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.